Detalles de la búsqueda
1.
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Lancet Microbe
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38878794
2.
Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis.
Drug Saf
; 46(1): 99-108, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369456
3.
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Hum Vaccin Immunother
; 18(1): 1981085, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614379
4.
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vaccine
; 39(45): 6628-6636, 2021 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34635373
5.
Frequency, pattern and etiology of nosocomial infection in intensive care unit: an experience at a tertiary care hospital.
J Ayub Med Coll Abbottabad
; 20(4): 37-40, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19999200
6.
Promising Biomarkers of Environmental Enteric Dysfunction: A Prospective Cohort study in Pakistani Children.
Sci Rep
; 8(1): 2966, 2018 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29445110
Resultados
1 -
6
de 6
1
Próxima >
>>